메뉴 건너뛰기




Volumn 10, Issue 8, 2013, Pages 425-

From ASCO - Gynaecological cancer: Advances in cervical cancer screening and treatment

(1)  Kirk, Rebecca a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ANTINEOPLASTIC AGENT; BEVACIZUMAB; CISPLATIN; PACLITAXEL; VINEGAR;

EID: 84881478416     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2013.109     Document Type: Note
Times cited : (1)

References (2)
  • 1
    • 84888264277 scopus 로고    scopus 로고
    • Effect of visual inspection with acetic acid (VIA) screening by primary health workers on cervical cancer mortality: A cluster randomized controlled trial in Mumbai, India [abstract]
    • Shastri, S. S. et al. Effect of visual inspection with acetic acid (VIA) screening by primary health workers on cervical cancer mortality: a cluster randomized controlled trial in Mumbai, India [abstract]. J. Clin. Oncol. 31 (Suppl.), a2 (2013)
    • (2013) J. Clin. Oncol. , vol.31 , Issue.SUPPL. .
    • Shastri, S.S.1
  • 2
    • 84884401355 scopus 로고    scopus 로고
    • Incorporation of bevacizumab in the treatment of recurrent and metastatic cervical cancer: A phase III randomized trial of the Gynecologic Oncology Group [abstract]
    • Tewari, K. S. et al. Incorporation of bevacizumab in the treatment of recurrent and metastatic cervical cancer: a phase III randomized trial of the Gynecologic Oncology Group [abstract]. J. Clin. Oncol. 31 (Suppl.), a3 (2013)
    • (2013) J. Clin. Oncol. , vol.31 , Issue.SUPPL. .
    • Tewari, K.S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.